Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.
about
Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the ratLow but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawalBehavioral Effects of Systemic, Infralimbic and Prelimbic Injections of a Serotonin 5-HT2A Antagonist in Carioca High- and Low-Conditioned Freezing Rats.A potential gastrointestinal link between enhanced postnatal maternal care and reduced anxiety-like behavior in adolescent ratsActions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions.Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects.Chronic cocaine self-administration attenuates the anxiogenic-like and stress potentiating effects of the benzodiazepine inverse agonist, FG 7142.The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding.Environmental Enrichment during Gestation Improves Behavior Consequences and Synaptic Plasticity in Hippocampus of Prenatal-Stressed Offspring RatsYohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals.Yohimbine anxiogenesis in the elevated plus maze requires hindbrain noradrenergic neurons that target the anterior ventrolateral bed nucleus of the stria terminalis5-HT2 ligands in the treatment of anxiety and depression.Central amygdala relaxin-3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats.5HT drugs in animal models of anxiety.Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspironeThe profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action.Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice.Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal.Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.The effects of drugs acting at GABA-benzodiazepine-barbiturate receptor complex on the behaviour of sleep-deprived mice.Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.Effects of two stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT.Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.Evidence for differential effects of 8-OH-DPAT on male and female rats in the Anxiety/Defense Test Battery.Dissociations in hippocampal 5-hydroxytryptamine release in the rat following Pavlovian aversive conditioning to discrete and contextual stimuli.Differential effects of forebrain 5-hydroxytryptamine depletions on Pavlovian aversive conditioning to discrete and contextual stimuli in the rat.Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.Similar effects of buspirone and chlordiazepoxide on a fixed interval schedule with long-term, low-dose administration.Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study.Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7 receptor antagonists and their psychotropic propertiesAnti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
P2860
Q28271831-0DA74F90-C372-412E-9545-12EA930738B9Q28325320-FEAF5428-F0F2-4B1E-B55A-4E0D302F1A97Q33881804-FFA0A46B-6381-4A3F-BCB9-20D258951C0FQ33896581-30A3434D-6987-4632-8024-84F1B0139B1BQ34344347-63D23945-ADEA-41EA-878F-6ED6C97F4A75Q34725259-E279D235-3AF8-48DA-B4E8-E00206A1688BQ35085940-A91208F1-B700-4D11-9E80-14754777CC37Q35630395-A4E1A331-1E8F-4A2C-B5F6-B50123DE69C4Q36090912-F353C0AF-8E72-41CA-8486-D9A5756259ABQ36572331-1F622721-52B0-4996-AF45-D86FB83948A9Q36799763-0CB0C616-98F2-4530-9DBE-092EF48C631FQ38037141-1DAF0384-C670-4258-89FD-B5C1BC9BC848Q38670902-3DC51AE3-5381-477F-915E-921C2063814DQ40601511-E180784B-FAA9-4117-BE61-50D7296CF1E4Q41899150-59761674-09A5-469A-A57C-17A1BFD6A9FCQ42141250-C61F8494-9D5F-47BC-A73A-AFD40F638D2EQ42690200-D79AB116-266E-4C4B-B45E-1DD2A1BBEE51Q44025232-1B9D7C5D-82E8-4B56-9CFA-70458EDE5798Q44652398-3F743261-90B6-4AD9-8BBE-263109DB6967Q46679052-9A65DA9C-3526-4AB6-ACE8-5C9109AB3477Q48003262-17D713BD-ADB6-463A-B1BE-AF9B037AEE15Q48308190-6B758D49-8F98-4B84-A980-5101564F823DQ48594691-B7F1DE1B-C83E-4A0B-B4FC-8D8C0CD4BBFFQ48827803-95DC82F7-85CB-4BA0-8055-97A422983E8EQ48882349-7E0448EA-0B52-40BA-B136-F12FCCFDEBB6Q51125505-3114F7C5-11F3-499B-8666-B61F18E24113Q51131200-97CB45B5-1F14-4166-917C-FF6E886863CCQ51136059-5B7D9E75-4EB9-4773-B931-FB30F2B4CB0EQ51138101-CA70AD9B-7342-466E-A66D-ADC76193B467Q51154327-862DA11A-B343-4E6A-A28C-CEB6CBCA2AAFQ52200908-495660A3-F41F-4014-9910-1B37508DCE4DQ52205672-5E5465A9-33DE-47BE-8C16-BAEE92AFFDB7Q52209292-DE79FB2D-5949-42DE-B7CD-E954B891EEB6Q52210638-92DD8CCB-772F-4DA1-9D67-CEB808953E95Q52870855-70FCE7E3-79FC-41E4-A65D-BE484FB8D121Q56980032-785729FC-F600-47F8-8AA8-0B1AFA545066Q58788199-C6C19BF3-952F-4B87-9045-F9442B2389BF
P2860
Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Selective agonists and antagon ...... ted plus-maze test in the rat.
@en
Selective agonists and antagon ...... ted plus-maze test in the rat.
@nl
type
label
Selective agonists and antagon ...... ted plus-maze test in the rat.
@en
Selective agonists and antagon ...... ted plus-maze test in the rat.
@nl
prefLabel
Selective agonists and antagon ...... ted plus-maze test in the rat.
@en
Selective agonists and antagon ...... ted plus-maze test in the rat.
@nl
P2093
P2860
P1476
Selective agonists and antagon ...... ted plus-maze test in the rat.
@en
P2093
P2860
P304
P356
10.1111/J.2042-7158.1987.TB03129.X
P577
1987-11-01T00:00:00Z